Potent <i>N</i>-(1,3-Thiazol-2-yl)pyridin-2-amine Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors with Excellent Pharmacokinetics and Low Affinity for the hERG Ion ChannelMark T. Bilodeau, George D. Hartman, William R. Huckle et al.|Journal of Medicinal Chemistry|2004Cited by 60
Design and synthesis of 3,7-diarylimidazopyridines as inhibitors of the VEGF-receptor KDRZhicai Wu, Kenneth A. Thomas, Mark E. Fraley et al.|Bioorganic & Medicinal Chemistry Letters|2004Cited by 42
Potent 2-[(pyrimidin-4-yl)amine}-1,3-thiazole-5-carbonitrile-based inhibitors of VEGFR-2 (KDR) kinaseJohn T. Sisko, George D. Hartman, Thomas J. Tucker et al.|Bioorganic & Medicinal Chemistry Letters|2005Cited by 35
A Novel Orally Bioavailable Inhibitor of Kinase Insert Domain-Containing Receptor Induces Antiangiogenic Effects and Prevents Tumor Growth <b> <i>in Vivo</i> </b>Laura Sepp‐Lorenzino, Kenneth A. Thomas, Elaine Rands et al.|Cancer Research|2004Cited by 26
Novel Flt-3/KDR inhibitor is effective against activated Flt-3 and is cytotoxic against Flt-3-driven leukemias in vitro and in vivoStephen C. Beck, Laura Sepp‐Lorenzino, Marian Iwamoto et al.|Cancer Research|2004Cited by 0